Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy.
Saved in:
| Title: | Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. |
|---|---|
| Authors: | Thunold S; Department of Oncology, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. solthu@ous-hf.no.; Institute for Cancer Research, Oslo University Hospital, Postbox 4950 Nydalen, Oslo, 0424, Norway. solthu@ous-hf.no., Hernes E; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Gyland Mikalsen LT; Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Farooqi S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Öjlert ÅK; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School, The University of Western Australia, Perth, WA, Australia., Nowak AK; Medical School, The University of Western Australia, Perth, WA, Australia.; National Centre for Asbestos-Related Diseases, University of Western Australia, Perth, Australia.; Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Szejniuk WM; Clinical Cancer Research Center, Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Nielsen SS; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark., Cedres S; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Perdigo MS; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Meltzer C; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Helland Å; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Malinen E; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Haakensen VD; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. |
| Source: | EJNMMI research [EJNMMI Res] 2026 Jun 20. Date of Electronic Publication: 2026 Jun 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Berlin Country of Publication: Germany NLM ID: 101560946 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2191-219X (Print) Linking ISSN: 2191219X NLM ISO Abbreviation: EJNMMI Res |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42322509 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual-time-point [<superscript>18</superscript>F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Thunold+S%22">Thunold S</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. solthu@ous-hf.no.; Institute for Cancer Research, Oslo University Hospital, Postbox 4950 Nydalen, Oslo, 0424, Norway. solthu@ous-hf.no.<br /><searchLink fieldCode="AU" term="%22Hernes+E%22">Hernes E</searchLink>; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gyland+Mikalsen+LT%22">Gyland Mikalsen LT</searchLink>; Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Farooqi+S%22">Farooqi S</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Öjlert+ÅK%22">Öjlert ÅK</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Francis+RJ%22">Francis RJ</searchLink>; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Nowak+AK%22">Nowak AK</searchLink>; Medical School, The University of Western Australia, Perth, WA, Australia.; National Centre for Asbestos-Related Diseases, University of Western Australia, Perth, Australia.; Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Szejniuk+WM%22">Szejniuk WM</searchLink>; Clinical Cancer Research Center, Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Nielsen+SS%22">Nielsen SS</searchLink>; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Cedres+S%22">Cedres S</searchLink>; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Perdigo+MS%22">Perdigo MS</searchLink>; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sørensen+JB%22">Sørensen JB</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Meltzer+C%22">Meltzer C</searchLink>; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Helland+Å%22">Helland Å</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Malinen+E%22">Malinen E</searchLink>; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Haakensen+VD%22">Haakensen VD</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560946%22">EJNMMI research</searchLink> [EJNMMI Res] 2026 Jun 20. <i>Date of Electronic Publication: </i>2026 Jun 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Berlin%22">Springer Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101560946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2191-219X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222191219X%22">2191219X </searchLink><i>NLM ISO Abbreviation: </i>EJNMMI Res |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42322509 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13550-026-01469-x Languages: – Code: eng Text: English Titles: – TitleFull: Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thunold S – PersonEntity: Name: NameFull: Hernes E – PersonEntity: Name: NameFull: Gyland Mikalsen LT – PersonEntity: Name: NameFull: Farooqi S – PersonEntity: Name: NameFull: Öjlert ÅK – PersonEntity: Name: NameFull: Francis RJ – PersonEntity: Name: NameFull: Nowak AK – PersonEntity: Name: NameFull: Szejniuk WM – PersonEntity: Name: NameFull: Nielsen SS – PersonEntity: Name: NameFull: Cedres S – PersonEntity: Name: NameFull: Perdigo MS – PersonEntity: Name: NameFull: Sørensen JB – PersonEntity: Name: NameFull: Meltzer C – PersonEntity: Name: NameFull: Helland Å – PersonEntity: Name: NameFull: Malinen E – PersonEntity: Name: NameFull: Haakensen VD IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 06 Text: 2026 Jun 20 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2191-219X Titles: – TitleFull: EJNMMI research Type: main |
| ResultId | 1 |